Position in TVTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,876,333
+$6,220,082 QoQ
Shares Held
156,246
+74.8% QoQ
Ownership
0.166%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 315 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TVTX Over Time
Shares Held
Position Value (USD)
Derivatives in TVTX
reported options exposure · as of Sep 30, 2025CallValue
$4,015,200
CallShares
168,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. TVTX ranks #30 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in TVTX
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,876,333 | 156,246 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,656,251 | 89,406 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $6,069,046 | 158,834 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,784,923 | 74,683 | Shares | Defined | 2025-11-13 | |
| 2025-09-30 | $4,015,200 | 168,000 | Call | Defined | 2025-11-13 | |
| 2025-06-30 | $2,486,400 | 168,000 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $1,018,535 | 68,820 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,183,919 | 66,067 | Shares | Defined | 2025-05-13 | |
| 2025-03-31 | $3,010,560 | 168,000 | Call | Defined | 2025-05-13 | |
| 2024-12-31 | $1,000,743 | 57,448 | Shares | Defined | 2025-02-13 | |
| 2024-12-31 | $2,926,560 | 168,000 | Call | Defined | 2025-02-13 | |
| 2024-09-30 | $2,350,320 | 168,000 | Call | Defined | 2024-11-13 | |
| 2024-09-30 | $555,849 | 39,732 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $349,678 | 42,540 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $262,964 | 34,107 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $291,796 | 32,458 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $856,718 | 95,830 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,887,681 | 122,896 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,582,799 | 70,378 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $67,820 | 3,225 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $131,771 | 5,348 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $103,339 | 4,265 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,095,996 | 42,530 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,875,590 | 60,425 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,118,068 | 46,106 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,073,032 | 210,626 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,773,165 | 151,108 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,056,565 | 112,147 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 RTRX | — | 97,199 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 RTRX | — | 90,252 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 RTRX | — | 22,862 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||